Weed Inc (OTCMKTS:BUDZ) Appears Ready To Rally

Weed Inc (OTCMKTS:BUDZ) is chunking upward to start the week- a good 5% – the cannabis stock is up a solid 29% since last week Friday. It seems like the market may start bubbling again with some news on the horizon for BUDZ.

The last time we heard from BUDZ they acquired a genomic research center in Southern Colorado called the Sangre Bioscience Center. The purpose of the center is to completely map the cannabis genus. Glenn E. Martin, CEO of WEED, Inc., stated, “The purchase of the Le Veta property is an important step to allow Sangre AgroTech to have a state-of-the-art facility to conduct its Cannabis genomic research and is a building block for WEED’s larger, global strategy of creating a vertically-integrated cannabis business. WEED is also happy to be a part of the greater La Veta community and plans to make a positive impact in the surrounding area and the State of Colorado in the years to come.”

Weed Inc (OTCMKTS:BUDZ) promulgates itself as a company that seeks to pursue full legalization of cannabis across America through a legal taxation with representation format.

The company is a USA-based public firm. WEED Inc. is a multi-national, multi-faceted, vertically-integrated world class Cannabis organization. WEED is structured as a holding company doing business through its divisions, wholly-owned subsidiaries, and strategically placed collaborative partners to achieve and promote our global brand.

WEED is dedicated to its global goals and outreach across the full spectrum of the Cannabis industry to find treatments and medical cures utilizing the Cannabaceae plant family. WEED does not grow, harvest, produce, or sell any substance in violation of US Federal law under The Federal Controlled Substances Act, and meets all standards of international law in the countries that WEED does business in.

According to company materials, “is a public company, trading on the Over The Counter quotation system. Investors and shareholders may view WEEDS stock info at OTCMarkets,com WEED will focus on purchasing land and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. Once cleared off the Schedule 1 of the Controlled Substance Act. WEED will look to purchase and/or establish its own wholesale/retail outlets. “RESEARCH is the KEY to the FUTURE”. To that effect WEED will open a Research Center in Perth Australia in Q1 2016.”

The company is run by its Founder and CEO Glenn E. Martin who has 46 years of advocacy and research in the cannabis space. The company’s goal is to create the highest quality cannabis agricultural centers that will raise the bar for the entire industry.

Subscribe below and we’ll keep you on top of what’s happening before $BUDZ stock makes its next move.

Besides being a big boost to the town of La Veta and the Southern Colorado economic system, BUDZ is looking to use the center’s research to fuel CBD oil strains specifically PTSD, MS and Autism. BUDZ bills itself as a true seed-to-sale company with multiple revenue options from equipment to actual cannabis sales.

Weed Inc (OTCMKTS:BUDZ) has a not really recovered from the high around the election, but the company is starting to rally. BUDZ has always been a nice stock to read about but it can be a little light on substance. This stock and its leadership need to actually put some effort into transparency and hard numbers. BUDZ has a $178.98M market cap and 99.99M shares out. For continuing coverage on shares of $BUDZ stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Disclosure: We hold no position in $BUDZ, either long or short, and we have not been compensated for this article.

Welcome to the Oracle Dispatch, a free online newspaper packed with exclusive content, news, articles and much more!
Each day you’ll receive the latest business and industry news, financial analysis and much more.
All this, and it’s free.
Join the thousands of Oracle Dispatch users who are already with us!
If you have any questions please visit contacts page.